Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayumi Ono

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 30, 2004
[Screening of antiangiogenic compound]Mayumi Ono
Cancer Science|August 30, 2008
Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategyMayumi Ono
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugsMayumi Ono, Michihiko Kuwano
Comparative Migration Studies|March 3, 2021
British and Japanese international retirement migration and creative responses to health and care challenges: a bricolage perspectiveKelly Hall, Mayumi Ono, Ayako Kohno
Histochemistry and Cell Biology|March 16, 2007
The EGFR inhibitor gefitinib suppresses ligand-stimulated endocytosis of EGFR via the early/late endocytic pathway in non-small cell lung cancer cell linesYukio Nishimura, Biborka Bereczky, Mayumi Ono
Legal Medicine (Tokyo, Japan)|April 19, 2025
Forensic significance of quantitatively analyzing methamphetamine in male reproductive organsNaoto Tani, Shigeki Oritani, Mayumi Ono, et al.
Organic & Biomolecular Chemistry|September 2, 2003
An experimental and theoretical study on the substituent effect of the permanganate oxidation of styrenesToshio Ogino, Hisashi Yaezawa, Osamu Yoshida, et al.
Cancer Science|March 24, 2019
Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancerMichihiko Kuwano, Tomohiro Shibata, Kosuke Watari, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Molecular targeting drugs--present status and future development]Michihiko Kuwano, Teruhiko Fujii, Mayumi Ono, et al.
Platelets|January 15, 2011
GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitroMayumi Ono, Yumiko Matsubara, Toshiro Shibano, et al.
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 30, 2004
[Screening of antiangiogenic compound]Mayumi Ono
Cancer Science|August 30, 2008
Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategyMayumi Ono
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugsMayumi Ono, Michihiko Kuwano
Comparative Migration Studies|March 3, 2021
British and Japanese international retirement migration and creative responses to health and care challenges: a bricolage perspectiveKelly Hall, Mayumi Ono, Ayako Kohno
Histochemistry and Cell Biology|March 16, 2007
The EGFR inhibitor gefitinib suppresses ligand-stimulated endocytosis of EGFR via the early/late endocytic pathway in non-small cell lung cancer cell linesYukio Nishimura, Biborka Bereczky, Mayumi Ono
Legal Medicine (Tokyo, Japan)|April 19, 2025
Forensic significance of quantitatively analyzing methamphetamine in male reproductive organsNaoto Tani, Shigeki Oritani, Mayumi Ono, et al.
Organic & Biomolecular Chemistry|September 2, 2003
An experimental and theoretical study on the substituent effect of the permanganate oxidation of styrenesToshio Ogino, Hisashi Yaezawa, Osamu Yoshida, et al.
Cancer Science|March 24, 2019
Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancerMichihiko Kuwano, Tomohiro Shibata, Kosuke Watari, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Molecular targeting drugs--present status and future development]Michihiko Kuwano, Teruhiko Fujii, Mayumi Ono, et al.
Platelets|January 15, 2011
GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitroMayumi Ono, Yumiko Matsubara, Toshiro Shibano, et al.
Pageof 13